GH Research (GHRS) Times Interest Earned (2021 - 2026)
GH Research (GHRS) posted quarterly Times Interest Earned of $93.39 for Q4 2025, down 87.73% year-over-year from $761.41 in Q4 2024, and down 88.16% quarter-over-quarter from $788.81 in Q3 2025.
Analysis
GH Research (GHRS) Times Interest Earned (2021 - 2026) Analysis & Trends
GH Research's Times Interest Earned history runs 5 years deep, the most recent figure standing at $93.39 for Q4 2025.
- In Q4 2025, Times Interest Earned fell 87.73% year-over-year to $93.39; the TTM figure through Dec 2025 stood at -$399.46 (down 258.0% YoY), while the FY2025 annual figure was $95.02, up 36.55% from the prior year.
- Times Interest Earned for Q4 2025 stood at $93.39, down from $788.81 in the prior quarter.
- The five-year high for Times Interest Earned was $1555.3 in Q3 2021, with the low at -$416.91 in Q4 2022.
- The 5-year median for Times Interest Earned is $48.9 (2023), against an average of $169.41.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned plunged 233.94% in 2024, then jumped 1031.25% in 2025.
- GH Research's Times Interest Earned stood at -$367.83 in 2021, then declined by 13.34% to -$416.91 in 2022, then surged by 76.52% to -$97.89 in 2023, then soared by 877.86% to $761.41 in 2024, then slumped by 87.73% to $93.39 in 2025.
- Business Quant data shows GHRS's Times Interest Earned at $93.39 in Q4 2025, $788.81 in Q3 2025, and -$84.51 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | GH Research | 1.72 Bn | 1.36 Bn | - | 234.40 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 234.40 |
| Mar 31, 2026 | 223.20 |
| Dec 31, 2025 | 185.74 |
| Sep 30, 2025 | 788.81 |
| Jun 30, 2025 | 84.51 |
| Mar 31, 2025 | 71.53 |
| Dec 31, 2024 | 72.31 |
| Sep 30, 2024 | 69.73 |
| Jun 30, 2024 | 74.26 |
| Mar 31, 2024 | 64.40 |
| Dec 31, 2023 | 59.04 |
| Sep 30, 2023 | 52.82 |
| Jun 30, 2023 | 55.45 |
| Mar 31, 2023 | 60.93 |
| Dec 31, 2022 | -74.57 |
| Sep 30, 2021 | 1,555.33 |
| Jun 30, 2021 | 445.50 |